1: Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol. J Pharmacol Exp Ther. 1987 Sep;242(3):1025-34. PMID: 2888869.
2: McCaffrey PM, Burke M, Riddell JG, Shanks RG. Studies of the agonist and antagonist activity of cicloprolol in man. Eur J Clin Pharmacol. 1988;34(6):569-75. doi: 10.1007/BF00615219. PMID: 3169110.
3: Weber S, Kahan A, Pinquier JL, Julien J, Rosenzweig P, Bianchetti G, Morselli PL, Dessault O, De Lauture D, Strauch G. Pharmacodynamic without pharmacokinetic interaction between cicloprolol, a partial beta 1-adrenoceptor agonist, and digoxin in healthy subjects. Br J Clin Pharmacol. 1990 Sep;30(3):411-6. doi: 10.1111/j.1365-2125.1990.tb03792.x. PMID: 1977438; PMCID: PMC1368144.
4: Cocco G, Alfiero R, Pouleur H. An evaluation of the safety of the beta- modulator cicloprolol in chronic heart failure. Clin Cardiol. 1992 Jan;15(1):38-42. doi: 10.1002/clc.4960150109. PMID: 1347258.
5: Hadfield SE, Slee SJ, Snow HM. The cardiovascular pharmacology of xamoterol, cicloprolol, prenalterol and pindolol in the anaesthetised dog. Br J Clin Pharmacol. 1989;28 Suppl 1(Suppl 1):78S-81S. doi: 10.1111/j.1365-2125.1989.tb03580.x. PMID: 2572262; PMCID: PMC1379883.
6: Bonandi L, Metra M, Niccoli L, Ettori F, Nodari S, Dei Cas L, Visioli O. Combined invasive and noninvasive study of left ventricular systolic and diastolic function following acute administration of cicloprolol to subjects with normal cardiac function. Cardiovasc Drugs Ther. 1992 Oct;6(5):513-7. doi: 10.1007/BF00055610. PMID: 1360256.
7: Rigaud M, Hamoir V, Chabanier A, Neveux E, Cazor JL, Bardet J, Bourdarias JP. Effets hémodynamiques au repos et à l'effort d'un nouvel agent bêta-agoniste partiel (cicloprolol) dans l'insuffisance cardiaque modérée [Hemodynamic effects at rest and exertion of a new partial beta-agonist (cicloprolol) in moderated cardiac failure]. Arch Mal Coeur Vaiss. 1988 Oct;81(10):1251-8. French. PMID: 2906233.
8: Silke B, Verma SP, Sharma SK, Frais MA, Reynolds G, Taylor SH. Comparative effects of atenolol and cicloprolol on cardiac performance in coronary heart disease. J Cardiovasc Pharmacol. 1989 Jan;13(1):155-61. PMID: 2468927.
9: Guinebault P, Haddouche A, Bianchetti G. High-performance liquid and gas chromatographic methods for the determination of cicloprolol. J Chromatogr. 1990 Feb 23;525(2):359-67. doi: 10.1016/s0378-4347(00)83412-x. PMID: 1970344.
10: Silke B, Verma SP, Sharma SK, Baig W, Jackson NC, Reynolds G, Frais MA, Taylor SH. Haemodynamic dose-response actions of cicloprolol in left ventricular dysfunction due to ischaemic heart disease. Int J Cardiol. 1987 Nov;17(2):127-36. doi: 10.1016/0167-5273(87)90124-0. PMID: 2890589.